The 9 Key KPIs for Med Spas in 2027

Why Med Spas Report Differently

Med spas are not salons, not dermatology practices, and not SaaS businesses, yet most operators borrow KPIs from all three and end up reporting numbers that mean nothing. A typical salon tracks chair utilization and service mix, but a med spa earns the majority of its gross profit on injectables that sit on a refrigerator shelf and expire 36 months from manufacture — so the relevant metric is syringe throughput per provider, not chair-hours.

A dermatology practice tracks CPT-coded encounters, but med spa revenue is overwhelmingly cash-pay and elective, which means the decision to rebook is a marketing decision, not a clinical one.

The 2027 wrinkle is that the AbbVie / Allergan toxin price increase of January 2027 pushed wholesale Botox above $5.20 per unit landed in most US markets, and Evolus Jeuveau and Revance Daxxify are now serious second-source plays. The unit economics have shifted enough that a 2024 KPI dashboard is materially wrong in 2027.

Operators who still track "monthly revenue" without breaking out Botox margin, membership ARR, and syringe-per-provider-day are flying blind. The nine KPIs below were chosen because each one has a 2027-specific benchmark sourced from AmSpa State of the Industry, MedSpa Insider operator surveys, AbbVie's BTX franchise commentary, and named operator interviews at chains like Ever/Body, Skin Spirit, and LaserAway.

The 9 KPIs, In Depth

1. Average Treatment Ticket (ATT)

Definition: Average revenue per transaction across all paying patients in a period. Formula: Total gross revenue / number of paid tickets. 2027 Benchmark: $425-$575 for full-service med spas with injectables; $285-$340 for laser-and-facial-only shops.

AmSpa's 2027 single-location average ticket lands at $487. Named example: Ever/Body (NYC, 12 locations) publicly references an ATT around $520 driven by Botox + filler combo visits. Failure mode: Discounting Botox to $9-$10 a unit to "build the file" crushes ATT without lifting LTV, because discount-acquired patients rebook at half the rate of full-price patients per AestheticsPro's 2027 retention study.

2. Membership Attach Rate

Definition: % of active patients enrolled in a paid monthly membership (e.g., $99-$149/mo with banked units or service credit). Formula: Active members / unique patients in last 365 days. 2027 Benchmark: 18-30%; top-quartile operators like Greenwich Medical Spa and Skin Spirit run 32-38%.

Why it matters: Members visit 2.3x more often and have a 90-day repeat rate of 78% vs 51% for non-members (MedSpa Insider 2027 panel of 412 clinics). Failure mode: Selling memberships as a discount instead of a banked-unit subscription — discount memberships cannibalize revenue; banked-unit memberships are pre-paid ARR.

3. Syringe Usage Per Provider Per Day

Definition: Total injectable syringes (toxin vials counted as one "session" equivalent, fillers counted per syringe) administered per full-time injector per clinical day. Formula: Syringes used / injector-days worked. 2027 Benchmark: 8-14 syringes/day for an experienced RN injector; 4-7 for a ramping injector.

Named example: LaserAway's injector productivity model targets 12+ per day per nurse; Ever/Body reports an internal target of 10. Failure mode: Padding the schedule with 15-minute Botox slots without filler upsell — drives syringes-per-day up but ATT down, hiding the real productivity problem.

4. 90-Day Repeat Visit Rate

Definition: % of patients who book a second paid visit within 90 days of their first. Formula: Patients with 2+ visits in 90d / new patients in cohort. 2027 Benchmark: 55-70% for injectable-led spas; 35-50% for facial/laser-led.

Best-in-class: 78% for membership-led clinics (per MedSpa Insider). Why 90 days: Botox duration is 12-14 weeks for ~70% of patients, so the 90-day rebook is the structural floor. Named example: Skin Spirit reportedly runs a 72% 90-day rebook, attributed to automated 10-week tap sequences.

Failure mode: Treating "retention" as a 12-month metric — by month 12 your patient has already defected to the place that texted them at week 10.

5. Social Following Growth Rate

Definition: Net new followers across Instagram + TikTok as a % of starting base, month over month. Formula: (Ending followers - starting followers) / starting followers. 2027 Benchmark: 3-6% MoM for a healthy local med spa; 8-15% for those running consistent UGC reels with named injector creators.

Engagement floor: 1.8% Instagram, 2.3% TikTok per Dash Social's 2027 wellness benchmarks. Named example: Alchemy 43 and Peachy built six-figure follower counts primarily on before/after Reels. Failure mode: Buying followers or running pure giveaway growth — engagement collapses below 0.5% and Instagram throttles reach, so the follower KPI looks great while booked appointments fall.

6. Botox Unit Landed Cost

Definition: True per-unit cost of toxin including wholesale price, freight, refrigeration loss, and expired-vial waste. Formula: (Vials purchased x landed price + waste) / units actually injected. 2027 Benchmark: $4.85-$5.40 per unit for Botox Cosmetic; $3.90-$4.50 for Jeuveau; $5.60-$6.20 for Daxxify (longer-duration premium).

Post-Jan-2027 AbbVie list price put unmanaged spas above $5.50/unit. Failure mode: Reporting "cost per vial" instead of "cost per injected unit" — 6-12% of toxin gets wasted at the end of a vial when reconstitution math is sloppy. A spa charging $13/unit retail with $5.40 cost + 10% waste has a real toxin margin of 54%, not 60%.

7. Revenue Per Available Provider Hour (RevPAH)

Definition: Gross revenue divided by total provider hours scheduled (whether booked or not). Formula: Period revenue / (providers x scheduled hours). 2027 Benchmark: $375-$525 for injector RNs; $220-$310 for laser techs; $140-$200 for estheticians.

Named example: Internal Ever/Body ops decks reportedly target $500+ RevPAH for injectors. Why it beats utilization: A 95%-utilized injector doing $9/unit Botox in 15-min slots earns less than a 75%-utilized injector doing Sculptra + Botox combos in 45-min slots.

Failure mode: Optimizing for booked % instead of dollar yield.

8. New-to-Returning Patient Mix

Definition: Share of monthly visits from net-new patients vs returning. Formula: New patient visits / total visits. 2027 Benchmark: 25-35% new is the healthy band.

Below 20%: Acquisition machine is broken; the file is aging. Above 45%: Retention is leaking and you are spending CAC to refill a bucket with a hole. Named example: LaserAway's rapid-expansion locations run 40-50% new in months 1-6, then settle to 30-35%.

Failure mode: Reporting only new patient count without the mix ratio — you can grow new while bleeding old, and the P&L looks fine until month 9.

9. Consult-to-Treatment Conversion

Definition: % of free or paid consults that result in a same-day or same-week paid treatment. Formula: Treatments booked from consult / total consults. 2027 Benchmark: 60-75% for in-person injectable consults; 35-50% for virtual consults.

Why it matters in 2027: Virtual consult volume is up 4x since 2024 thanks to GLP-1 cross-sell funnels routing patients into aesthetic clinics. Lower virtual conversion is structural; ignoring it means missing $200-$400 of CAC efficiency per consult. Named example: Skin Spirit's in-person consult conversion reportedly sits in the low 70s.

Failure mode: Counting price-quote phone calls as "consults" — inflates the denominator and tanks the metric.

Real Operators

• Ever/Body (NYC + LA, ~12 locations, Burch Creative backed): publicly references ATT around $520, internal injector RevPAH target $500+, membership attach reportedly in the high 20s%. Heavy on branded injector profiles for social growth.
• LaserAway (~170 locations, largest US chain): laser-led so blended ATT closer to $310, but syringes-per-injector-day target 12+, new patient mix 40-50% in young clinics settling to 30%. Aggressive TikTok-led social with double-digit MoM growth in 2027.
• Skin Spirit (60+ locations, west coast premium): membership attach 32-38%, 90-day repeat reportedly 72%, consult conversion low-70s. Reference for the banked-unit membership model.
• Ideal Image (~150 locations): recovering from 2023-2024 turbulence; 2027 KPIs emphasize RevPAH and consult conversion as the unit-economic levers in the reset.
• Alchemy 43 (~20 locations, LA-led): social-first brand with 6%+ MoM follower growth historically; ATT ~$385 (more Botox-only by design); membership penetration low 20s%.

Failure Modes

1. Tracking cost-per-vial, not cost-per-injected-unit. Waste is 6-12% of toxin. Spas reporting "60% Botox margin" are usually running 52-55% real margin after waste and the Jan-2027 AbbVie price increase.
2. Confusing "retention" with "12-month retention." By month 9, you have already lost the customer to the spa that texted them at week 10. 90-day rebook is the only retention KPI that catches the leak in time.
3. Discount memberships. Selling 10% off all services as a $99/mo membership pays you nothing and trains the patient to wait for promos. Banked-unit memberships (15 units/mo at member rate) are pre-paid ARR; discount memberships are not.
4. Follower vanity. A 50k follower count with 0.4% engagement books fewer treatments than a 6k follower count with 3.2% engagement. Track engaged-follower growth, not raw growth.
5. Treating consults as a conversion-free top of funnel. A 65% in-person conversion versus 45% virtual conversion is a 20-point CAC efficiency gap worth thousands per month.
6. Booking 15-minute Botox slots to hit syringe-per-day. Drives the syringe KPI up while ATT, RevPAH, and 90-day repeat all degrade. Optimize for dollar yield per provider hour, not transaction count.

Reporting Cadence

• Daily: Syringes per provider, RevPAH, new-vs-returning ticket count.
• Weekly: ATT, consult-to-treatment conversion, social engagement and net follower delta, no-show rate (as the leading indicator of 90-day repeat).
• Monthly: Membership attach rate, 90-day repeat cohort (rolling), Botox unit landed cost (with waste calc), social growth MoM, new-to-returning mix.
• Quarterly: Full LTV-to-CAC by acquisition channel, membership churn, injector productivity ranking, vendor mix (Botox vs Jeuveau vs Daxxify) and resulting blended unit cost.

30 / 60 / 90 Day Implementation

Days 1-30 — Instrument. Connect the PMS (Aesthetic Record, Boulevard, PatientNow) to a single dashboard. Lock formulas in writing. Pull last-90-day baselines. Do not skip baseline — without it you cannot defend any future improvement claim.

Days 31-60 — Diagnose. Rank the nine KPIs against 2027 benchmarks. Pick the bottom three. Conduct 5 operator interviews (front desk, injector, esthetician, owner, marketing) and a chart audit of 50 random patients to ground the numbers in reality.

Days 61-90 — Optimize. Ship the two highest-leverage interventions: typically a 10-week automated rebook sequence (lifts 90-day repeat 8-15 points) and a banked-unit membership relaunch (lifts attach 6-12 points). If toxin margin is the gap, run a 30-day Jeuveau pilot at 2-3 injector chairs and measure patient satisfaction + repeat rate against Botox.

FAQ

Q: We are a small two-room med spa. Do we really need all nine? A: Track all nine, but only manage the bottom three at any given time. Trying to move all nine at once produces no movement on any.

Q: Our ATT is $610 — above benchmark. Is that good? A: Probably, but check it against new-to-returning mix. A $610 ATT with 15% new patient mix means you are over-indexed on heavy-spending regulars and your acquisition is failing.

Sustainable ATT above benchmark is great; ATT above benchmark with a starving top-of-funnel is a 9-month timer.

Q: How do I handle the Allergan price increase in my KPI targets? A: Raise retail $1-$2 per Botox unit, run a 60-day Jeuveau pilot at a 15-20% wholesale discount, and rebuild your Botox-unit-landed-cost target around a 70/30 Botox/Jeuveau blend if patients tolerate it.

Do not absorb the price increase silently — margin compression is the #1 way med spas lose money in 2027.

Q: My TikTok grew 22% last month. Why is RevPAH flat? A: Because follower growth is not booking growth. Check link-click-to-booking conversion in your booking tool. A viral reel often brings followers who never book. Track booked appointments attributed to social as a sub-metric.

Q: What is the single most overlooked KPI? A: Botox unit landed cost with waste. Most operators report list price per vial as their cost and never measure actual units injected, leaving 4-8 margin points on the table every month.

Sources

• American Med Spa Association (AmSpa) — 2025 and 2027 Medical Spa State of the Industry Reports — single-location revenue averages, membership penetration data.
• MedSpa Insider — 2027 Operator Panel (412 clinics) — repeat-visit and membership attach benchmarks.
• AbbVie 2026 Q4 and 2027 Q1 earnings calls — Botox Cosmetic franchise pricing commentary and US aesthetics segment performance.
• Evolus Inc. 2027 investor materials — Jeuveau pricing strategy and US market share commentary.
• Revance Therapeutics 2027 investor materials — Daxxify pricing, duration positioning.
• Dash Social — 2027 Health & Wellness Industry Benchmark Report — Instagram and TikTok engagement and growth norms.
• AestheticsPro and PatientNow PMS aggregate benchmark reports, 2027 — RevPAH, syringe-per-provider, consult conversion norms.
• Modern Aesthetics Magazine and The Aesthetic Guide, 2026-2027 operator interviews — Ever/Body, Skin Spirit, Alchemy 43, LaserAway operator commentary.
• AmSpa Boot Camp 2027 financial benchmarking sessions — unit economics, waste, and margin frameworks.
• Bloomberg Businessweek, "How Med Spas Conquered America" (2024) and follow-up coverage 2026-2027 — chain economics and consumer trends.